Mirnite 30 Tablet
Prescription Required
Product introduction
Mirnite 30 Tablet is used in the treatment of depression. This medicine works by increasing the level of chemical messengers (serotonin and noradrenaline) in the brain that help calm the brain and relax the nerves, thus treating your depression.
Mirnite 30 Tablet is used to treat depression.
Mirnite 30 Tablet is used to treat depression.
Uses of Mirnite Tablet
Benefits of Mirnite Tablet
In Treatment of Depression
Mirnite 30 Tablet helps in maintaining the balance of certain chemicals in the brain that affect mood and behavior. This improves your mood, relieves anxiety, tension, helps you sleep better, and increases your energy levels. Mirnite 30 Tablet prevents extreme mood changes and helps you feel less agitated. You may experience fewer episodes of depression and low mood.
It can take several weeks for Mirnite 30 Tablet to work and you may still feel low during this time. It is likely that you will take this medicine for at least six months but possibly much longer. It needs to be taken regularly to work effectively. Do not stop taking it unless your doctor tells you to.
It can take several weeks for Mirnite 30 Tablet to work and you may still feel low during this time. It is likely that you will take this medicine for at least six months but possibly much longer. It needs to be taken regularly to work effectively. Do not stop taking it unless your doctor tells you to.
Side effects of Mirnite Tablet
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Mirnite
- Sleepiness
- Dryness in mouth
- Increased appetite
- Headache
- Weight gain
How to use Mirnite Tablet
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Mirnite 30 Tablet may be taken with or without food, but it is better to take it at a fixed time.
Safety advice
Alcohol
UNSAFE
It is unsafe to consume alcohol with Mirnite 30 Tablet.
Pregnancy
CONSULT YOUR DOCTOR
Mirnite 30 Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Breast feeding
CONSULT YOUR DOCTOR
Mirnite 30 Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
The baby should be monitored for behavioral side effects and adequate growth.
The baby should be monitored for behavioral side effects and adequate growth.
Driving
UNSAFE
Mirnite 30 Tablet may cause side effects which could affect your ability to drive.
Mirnite 30 Tablet can affect your concentration or alertness. This may impair your driving ability.
Mirnite 30 Tablet can affect your concentration or alertness. This may impair your driving ability.
Kidney
CAUTION
Mirnite 30 Tablet should be used with caution in patients with kidney disease. Dose adjustment of Mirnite 30 Tablet may be needed. Please consult your doctor.
Liver
CAUTION
Mirnite 30 Tablet should be used with caution in patients with liver disease. Dose adjustment of Mirnite 30 Tablet may be needed. Please consult your doctor.
What if you forget to take Mirnite Tablet?
If you miss a dose of Mirnite 30 Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
Mirnite 30 Tablet
₹23.3/Tablet
Mirtaz 30 Tablet
Sun Pharmaceutical Industries Ltd
₹19/tablet
18% cheaper
Mirazep 30mg Tablet
Micro Labs Ltd
₹14.6/tablet
37% cheaper
Miz 30mg Tablet
Tripada Biotec Pvt Ltd
₹10.3/tablet
56% cheaper
Mirtakem 30mg Tablet
Alkem Laboratories Ltd
₹21.6/tablet
7% cheaper
Mirtee 30mg Tablet
Talent India
₹14.1/tablet
39% cheaper
Quick tips
- Mirnite 30 Tablet starts to work more quickly than other antidepressants.
- Avoid driving or operating dangerous machinery as it may decrease alertness.
- Avoid consuming alcohol when taking the Mirnite 30 Tablet, as it may cause excessive drowsiness and calmness.
- If your doctor asks you to stop Mirnite 30 Tablet, you should reduce the dose slowly over 4 weeks. You should not discontinue it abruptly.
- Notify your doctor immediately if you develop a sore throat or fever or stomatitis during treatment with Mirnite 30 Tablet.
Fact Box
Chemical Class
Piperazinoazepine Tetracyclic
Habit Forming
No
Therapeutic Class
NEURO CNS
Action Class
Noradrenergic and specific serotonergic antidepressants (NASSAs)
Patient concerns
User feedback
Patients taking Mirnite 30 Tablet
Once A Day
95%
Twice A Day
5%
FAQs
Is Mirnite 30 Tablet addictive?
No, Mirnite 30 Tablet is not addictive. Patient should follow the advice of the doctor regarding its use
Is Mirnite 30 Tablet safe?
Mirnite 30 Tablet is safe if used at prescribed dose and duration as advised by your doctor
Can I take Mirnite 30 Tablet forever?
No, patient should take Mirnite 30 Tablet for the given duration as advised by your doctor
Related ayurvedic ingredients
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Stahl SM, editor. Mirtazapine. In: Stahl's Essential Pschopharmacology: Prescriber's Guide. 5th ed. New York, New York: Cambridge University Press; 2014. pp. 441-45.
- Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 925-26.
Marketer details
Name: Intas Pharmaceuticals Ltd
Address: Chinubhai Centre, Off. Nehru Bridge, Ashram Road, Ahmedabad - 380009. Gujarat. India.
Country of origin: India
Lab tests offered by us
Related/Popular tests
NOT FOR SALE
We do not facilitate sale of this product at present